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Abstract
Background: Since the schools vaccination campaign in 1994, measles has been eliminated from
England. Maintaining elimination requires low susceptibility levels to keep the effective
reproduction number R below 1. Since 1995, however, MMR coverage in two year old children has
decreased by more than 10%.
Methods: Quarterly MMR coverage data for children aged two and five years resident in each
district health authority in England were used to estimate susceptibility to measles by age. The
effective reproduction numbers for each district and strategic health authority were calculated and
possible outbreak sizes estimated.
Results: In 2004/05, about 1.9 million school children and 300,000 pre-school children were
recorded as incompletely vaccinated against measles in England, including more than 800,000
children completely unvaccinated. Based on this, approximately 1.3 million children aged 2–17 years
were susceptible to measles. In 14 of the 99 districts, the level of susceptibility is sufficiently high
for R to exceed 1, indicating the potential for sustained measles transmission. Eleven of these
districts are in London. Our model suggests that the potential exists for an outbreak of up to
100,000 cases. These results are sensitive to the accuracy of reported vaccination coverage data.
Conclusion: Our analysis identified several districts with the potential for sustaining measles
transmission. Many London areas remain at high risk even allowing for considerable under-
reporting of coverage. Primary care trusts should ensure that accurate systems are in place to
identify unimmunised children and to offer catch-up immunisation for those not up to date for
MMR.
Background
Measles vaccination was introduced in the UK in 1968 for
children in the second year of life [1]. Coverage gradually
improved from approximately 50% during the 1970s to
86% when MMR vaccine replaced single antigen vaccine
in 1988, and reached 92% in 1995. As a result, measles
epidemics, which had occurred biennially in the pre-vac-
cination period with hundreds of thousands of notified
cases, became smaller and less frequent. Control of mea-
sles reached a new level following a national vaccination
campaign in November 1994, when measles-rubella vac-
cine was offered to all school children aged 5–16 years to
prevent a predicted epidemic of measles; coverage of 92%
was achieved and endemic transmission of measles was
interrupted [2]. In 1996, a second dose of MMR was
added to the routine vaccination schedule at around 4
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years of age. Despite the occurrence of occasional out-
breaks, caused by limited secondary spread from
imported cases, measles has been eliminated in England
and Wales for more than 10 years [3].
To maintain measles elimination, the effective reproduc-
tion number, R, (the average number of secondary cases
infected by a typical infectious case) needs to remain
below 1 [4]. This can be achieved through maintaining
low levels of susceptibility by vaccinating a high propor-
tion of the population. The European region of the World
Health Organisation (WHO) defined target levels of sus-
ceptibility to sustain measles elimination: the level of sus-
ceptibility in 1–4 year olds should be less than 15%, in 5–
9 year olds less than 10% and in all older cohorts less than
5% [5]. As around 90% of individuals are protected from
measles after a first dose of vaccine, and 99% after a sec-
ond dose, to achieve these target levels requires high vac-
cination coverage to be sustained [6].
Coverage for MMR vaccine in two year old children in
England fell from the peak of 92% in 1995 to reach the
low of 80% in 2003. Coverage in London is lower than in
the rest of England. We have used routine data on vaccine
coverage in two and five year old children to estimate the
level of susceptibility, and hence the reproduction
number for measles in England. These results can be used
to predict future control of measles and to estimate the
possible impact of measles becoming re-established [7].
Methods
Vaccination Coverage
Between 1995 and 2002, quarterly and annual data on
coverage of MMR in two and five year old children, col-
lected as part of the COVER (Cover of Vaccination Evalu-
ated Rapidly) programme, was available by former district
health authorities (DHA) [8]. Since the reorganisation of
the NHS in 2002, data for England is collected from pri-
mary care trusts (PCTs). To provide consistent data for all
childhood cohorts, coverage from each PCT was aggre-
gated to the district health authority (DHA) configuration
prior to 2002 and to the Strategic Health Authority (SHA)
configuration as over the period 2002–2006.
At age two years the denominator and the number of
these children who have received one dose of MMR are
reported; at age five years the denominator, the number of
these children who have received at least one dose of
MMR, and the number who have received two doses of
MMR are reported. This enables the proportion of the
cohort who have received no doses, one dose only and
two or more doses to be calculated.
Three procedures were adopted to deal with missing and
anomalous coverage data.
1) Interpolation was performed to eliminate inconsistent
and missing data for any one quarter. When data for a sin-
gle quarter was missing, the data was assumed to be the
same as the previous quarter. Where data for more than
one successive quarter was not available, linear interpola-
tion from the last available quarter to the next available
quarter was used.
2) The coverage of MMR in children born in 1990 and
1991 was not captured by routine data at five years of age,
so coverage of the first dose at this age was assumed to be
the same as for children born after March 1992 (available
from COVER). Children born between January 1990 and
March 1992 were neither in the target age group for the
national MR catch-up campaign in 1994 nor eligible for
routine MMR2, but were scheduled to receive a second
dose in a catch-up in October 1996. Coverage in this
group varied from 47.6% in South Thames region to
66.8% in Northern and Yorkshire and so it was assumed
that 50% of these cohorts received the second dose.
3) Data at age two years is believed to be reasonably accu-
rate, but coverage at age five years is thought to under-esti-
mate the true coverage in many trusts [9]. This may be
caused by children who have left the area not being
removed from the denominator or by incomplete record-
ing of vaccination history for children who move into the
area. For example, eight DHAs reported a lower vaccina-
tion coverage for one dose at five years than for the same
cohort at two years of age. To correct this problem, cover-
age at five years of age was corrected to be at least 3%
higher than the two year old figure in each district. This
increase in coverage was the mean increase observed
between two and three years of age in sentinel trusts.
In addition, a sensitivity analysis was conducted to esti-
mate the potential impact of under-estimating coverage.
An audit of data quality for children born between July
and September 1995 in 12 London PCTs in 2001 sug-
gested that around 24% (201/836) of children recorded as
unvaccinated for MMR at five years of age had received at
least one dose of vaccine. Therefore, our analysis was
repeated assuming that 10%, 20%, 30%, 40% and 50% of
children recorded as unvaccinated had received one dose
of vaccine and that 10%, 20%, 30%, 40% and 50% of
those who were recorded as receiving a single dose had
also received the second dose.
Susceptibility
The relevant quarterly birth cohorts were aggregated to
approximate each school year (born September–August)
and vaccine coverage for MMR1 and MMR2 calculated.
For example, children born between October 1999 and
September 2000 comprised the four year old cohort in the
school year 2004/2005. Susceptibility was then estimatedBMC Public Health 2008, 8:338 http://www.biomedcentral.com/1471-2458/8/338
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for the pre-school group (aged 0–4 years), infant and jun-
ior school (aged 5–10 years), secondary school (aged 11–
17 years), college (18–24 years) and older (25 years or
more) [10].
Cohorts born since 1990 have almost no exposure to nat-
ural measles infection, so the proportion susceptible in
each age cohort is calculated as follows:
Children are assumed to be immune for the first six
months of life through maternal antibody. For cohorts
born before 1990, susceptibility was assumed to be 5% for
secondary school and college (14–24 years) and 2% for
older (25 years+) based upon sero-prevalence studies con-
ducted after the national vaccination campaign [11,12].
To calculate the susceptibility to measles in years after
2004/2005 it was assumed that vaccination coverage
remained stable at 2004/2005 levels. This assumption was
necessary for two reasons. First, coverage data from April–
June 2005 to date has been incomplete due to problems
with the implementation of new child health computer
systems in several London PCTs [13]. Second, from Octo-
ber 2006 reconfiguration of the number of PCTs in Eng-
land from 303 to 152, means that mapping these data to
old DHA areas would be more complex [14].
Effective Reproduction Number
The effective reproduction number (R) for each previous
DHA and SHA was calculated from the Next Generation
Matrix (NGM) accounting for the proportion susceptible
in each age group [11,15]. This matrix accounts for age-
specific heterogeneity in measles transmission. The values
for a totally susceptible population are shown below,
which give an R0 of 10.7.
For areas where R exceeds one, the potential outbreak size
was estimated as twice the number of infections required
to reduce R to 1 in that area [3,16].
Results
Coverage of English children born between September
1992 and August 2002 by five years of age ranged from
89.5% to 94.7% for at least one dose of MMR and from
73.7% to 75.0% for two doses (Figure 1). Coverage of
MMR in London was lower than in England overall by 7%
(for one dose) and 16% (for two doses) (Figure 1). Cov-
erage at five years declined over time, by 5.3% for MMR1
and 0.8% for MMR2
Figure 2 displays the estimated vaccination status for each
birth cohort in England. The proportion unvaccinated has
risen from 5.1% in the 11 year old cohort to 10% in the 5
year cohort.
Table 1 presents the estimated MMR vaccination status of
children in each school age group using cleaned routine
data. In all 1.9 million school children (5–17 years) and
0.3 million pre-school children are incompletely vacci-
nated for their age (i.e. have not received the scheduled
doses). Of these, more than 800,000 children are com-
pletely unvaccinated. The number of susceptible children
between 2 and 17 years was estimated to be 1.1 million in
2004/2005 (Table 1). Using our highest estimate of mis-
classification, if 50% of children recorded as unvaccinated
were actually partially vaccinated and the same propor-
tion of partially vaccinated children actually fully vacci-
nated, the revised numbers would be 1.6 million
incompletely vaccinated children, (of whom 0.4 million
completely unvaccinated) leading to 0.7 million suscepti-
ble children.
Susceptibility by birth cohort
Figure 3 shows the susceptibility of each school year
cohort in England (all districts combined) calculated from
the cleaned routine data and using estimates of vaccine
efficacy. The overall proportion susceptible was 27%
among 2–4 year olds (born 2000–2002), 13% among
children among primary school children (5–10 year olds)
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Reported MMR vaccination coverage at five years of age in  England and London, 1992–2004 Figure 1
Reported MMR vaccination coverage at five years of 
age in England and London, 1992–2004. (MMR1 for 
children who received at least 1 dose and MMR2 for children 
who received two doses).BMC Public Health 2008, 8:338 http://www.biomedcentral.com/1471-2458/8/338
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and 9% among secondary school children. However there
was considerable variation between districts ranging from
19% – 46% and 4% – 27% in 2–4 and 5–10 year olds
respectively. The majority of susceptible children are com-
pletely unvaccinated with MMR: of susceptible primary
school children, 74% have received 0 doses, 23% a single
dose, and 3% two doses.
Calculated values of R
The number of DHAs in 28 SHAs in four different R bands
are shown in Table 2. In 14 districts the levels of suscepti-
bility were sufficiently high for R to exceed 1, indicating
the potential for sustained measles transmission. Eleven
of these 14 DHAs are located in London, with only 5
DHAs in London having R below 1. In a further seven
DHAs, R was close to the threshold in the range 0.90–
0.99, 10 DHAs in the range 0.80–0.89, and 68 DHAs had
R values lower than 0.8.
When the data are analysed by SHA rather than DHA, only
four SHAs (all in London) appear at risk of sustained mea-
sles transmission (Figure 4).
Future control
If coverage remained stable after 2004/05, the total
number of susceptible children aged 2–17 years would
increase to around 1.2 million by 2007/8. After this time
the entire school population would comprise cohorts not
covered by the 1994 national vaccination campaign. Thus
in SHAs that did not achieve higher coverage, the increase
in susceptibility would further increase the value of R (Fig-
ure 5).
If the COVER data give a true indication of the vaccination
coverage in London, (0% under-reporting, Figure 5a) then
R has exceeded 1 in all five London SHAs since 2004/5,
and would be as high as 1.34 in South East London. In
these circumstances, it is surprising that no major epi-
demic of measles has already occurred, given the frequent
introductions of imported cases. This therefore supports
the belief that COVER data underestimates measles vacci-
nation coverage in London, but the degree is uncertain.
However, unless at least 50% of those reported as unvac-
cinated have received measles containing vaccine, the
potential for an epidemic in one or more SHAs in London
is reached by 2007/8 (Figure 5).
Outbreak size
The potential outbreak sizes are also sensitive to under-
estimation of vaccination coverage. The total potential
sizes for the DHAs where R exceeds 1 and are shown in
Table 3.
Depending on the degree of under-estimation of vaccina-
tion coverage assumed, the model suggests that in 2007/8
the potential exists for a measles outbreak of up to approx-
imately 100,000 cases. Most of these cases would be in
school age children in London (Table 3).
Derived vaccination status by age, 2004/5: a) England, b) Lon- don Figure 2
Derived vaccination status by age, 2004/5: a) England, 
b) London.
Table 1: Numbers of children (000s) by vaccination status and number of susceptibles by age group in England in 2004.
School cohort (approximate age group) Total MMR vaccine received Susceptibles n (%)
None One dose Two doses
Pre-school (2–4 years old) 1663 320 1343 0 454 (27%)
Primary school (5–10 years old) 3582 271 627 2684 360 (13%)
Secondary school (11–17 years old) 3656 211 826 2619 320 (9%)BMC Public Health 2008, 8:338 http://www.biomedcentral.com/1471-2458/8/338
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Discussion
Our analysis has identified several DHAs and SHAs in
England with the potential for sustaining measles trans-
mission. Among 99 former DHAs, fourteen have R values
above 1, meaning that they run the risk of re-establish-
ment of measles transmission in the community. Such
transmission could lead to an outbreak involving many
thousands of measles cases. A measles epidemic in Italy in
2002 led to around 40,000 cases, with direct costs esti-
mated at between  9.9 and  12.4 million, and total costs
around  14.8 million [17]. With such information, the
outbreak sizes estimated in this paper can be a valuable
tool to estimate the epidemic costs and the cost effective-
ness of possible interventions in England, such as a catch-
up campaign.
Our analysis ignores immunity through natural infection
in children aged under 17 years, as the incidence of mea-
sles has been too low to have a significant effect in the
cohorts considered. The last national epidemic was in
1988 and the incidence declined further following the
national vaccination campaign in November 1994 [2].
The quality of the COVER data is a weakness of this study,
as it is likely to underestimate the true vaccine coverage, as
some vaccinations are not be recorded on the child health
computer system and the total number of children (the
denominator) may be inaccurate [9,18]. There has been
no published validation of data held for children aged five
years, but it is expected that the quality of coverage data
would decline with the age of the child as movements out
of the denominator are often not recorded. Data is less
accurate in populations of high mobility, and therefore
the accuracy of COVER data for London is likely to be
worse than for the rest of country. Outside of London,
some of the DHAs with R above the epidemic threshold
are known to have problems with data accuracy. Our esti-
mates of susceptibility to measles by age in England are
consistent with data from serological surveillance [12].
Unfortunately few samples in these serosurveys are col-
lected in London, so these data do not reduce the uncer-
tainty regarding vaccination status and susceptibility in
London. Even after allowing for considerable under-esti-
mation of coverage, however, many London areas still
remain at high risk. In addition, unless routine coverage
can be further improved and sustained, the total number
of susceptibles will be expected to increase each year.
Although there has been an increase in MMR1 coverage at
two years since 2003, this is offset by a small decline at
five years, suggesting that further accumulation of suscep-
tibles will lead to a higher risk of measles outbreaks in the
future [19].
In response to earlier analyses of measles risk for London
DHAs, primary care trusts across the city conducted a
catch-up campaign among primary school aged children
to reduce the number of susceptibles in London [6]. To
eliminate the risk of a major outbreak, the campaign
would have had to vaccinate 40% of unvaccinated pri-
mary school children. More than 40,000 children in this
age group were identified and vaccinated by the cam-
paign, including over 17,000 previously unvaccinated
children. Initial evaluation indicates, however, that the
campaign has achieved only a modest reduction to the
epidemic risk in London and that endemic measles trans-
mission risk remains high in several health districts [20].
Each health area should review the vaccination status of
school children born since 1990 in order to validate the
coverage data, and if necessary, to focus on reducing the
proportion of children who are completely unvaccinated
against measles. The threat of re-establishing measles
transmission could be removed if the proportion of each
cohort susceptible to measles was reduced to less than
10% in primary school and to less than 5% in secondary
school. Opportunities to improve routine coverage need
to be reinforced and supplementary vaccination initia-
tives for children already attending school will also have
Calculated proportion susceptible to measles, 2004/5 by age  and vaccination status: a) England, b) London Figure 3
Calculated proportion susceptible to measles, 2004/5 
by age and vaccination status: a) England, b) London.BMC Public Health 2008, 8:338 http://www.biomedcentral.com/1471-2458/8/338
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to be taken in some areas. Catching-up children born
between 1997 and 2003, the cohorts most affected by the
decline in MMR coverage should be a priority. A catch-up
programme of this type has recently been announced by
the Chief Medical Officer [21]. Later cohorts can then be
assessed at school entry on a routine basis. A further
opportunity at secondary school entry, when a higher
level of immunity is required to prevent transmission,
should be formalised in each health area. To reduce the
number of young adults leaving school susceptible to
measles, mumps or rubella, MMR vaccine should also be
offered to all unvaccinated or partially vaccinated adoles-
cents at the time of the school leaving booster. If this final
opportunity is not taken, adults will be difficult to access
in the event of an increase in incidence. This problem has
been graphically illustrated by epidemics of rubella in
1996/7 and mumps in 2004/5 [3,4].
Conclusion
We identified several areas with the potential for sustain-
ing measles transmission. A number of former London
health districts remained at high risk of a measles epi-
demic even allowing for considerable under-reporting of
Table 2: Number of District Health Authorities (DHAs) in different R bands in 28 Strategic Health Authorities (SHAs) in 2004/05
SHA name >= 1 0.9 – 0.99 0.8 – 0.89 <0.8
NORFOLK, SUFFOLK AND CAMBRIDGESHIRE HA 3
BEDFORDSHIRE AND HERTFORDSHIRE HA 1 2
ESSEX HA 2
NORTH WEST LONDON HA 3 1
NORTH CENTRAL LONDON HA 1 2
NORTH EAST LONDON HA 1 2
SOUTH EAST LONDON HA 3
SOUTH WEST LONDON HA 3
NORTHUMBERLAND, TYNE & WEAR HA 4
COUNTY DURHAM AND TEES VALLEY HA 1 1
NORTH AND EAST YORKSHIRE AND NORTHERN LINCOLNSHIRE 3
WEST YORKSHIRE HA 2 2
CUMBRIA AND LANCASHIRE HA 5
GREATER MANCHESTER HA 1 4
CHESHIRE & MERSEYSIDE HA 1 2 3
THAMES VALLEY HA 1 2
HAMPSHIRE AND ISLE OF WIGHT HA 1 3
KENT AND MEDWAY HA 2
SURREY AND SUSSEX HA 1 1 1 1
AVON, GLOUCESTERSHIRE AND WILTSHIRE HA 4
SOUTH WEST PENINSULA HA 3
DORSET AND SOMERSET HA 1
SOUTH YORKSHIRE HA 1 3
TRENT HA 1 1 4
LEICESTERSHIRE, NORTHAMPTONSHIRE AND RUTLAND HA 2
SHROPSHIRE AND STAFFORDSHIRE HA 3
BIRMINGHAM AND THE BLACK COUNTRY HA 1 5
COVENTRY, WARWICKSHIRE, HEREFORDSHIRE AND WORCESTERSHIRE 4
Total 14 7 10 68
R values in 28 Strategic Health Authorities in England, 2004/ 05 Figure 4
R values in 28 Strategic Health Authorities in Eng-
land, 2004/05.BMC Public Health 2008, 8:338 http://www.biomedcentral.com/1471-2458/8/338
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(a-f). Evolution of the effective reproduction number, R, from 2004–05 to 2008–09 in the 28 Strategic Health Authorities in  England for six possible scenarios for the under-estimation of vaccination coverage (the five SHAs in London are shown in red);  the proportion of children recorded as unvaccinated who had received one dose and the proportion of children recorded as  having received a single dose who had received two doses was assumed to be : a) 0%, b) 10%, c) 20%, d) 30%, e) 40% and f)  50% Figure 5
(a-f). Evolution of the effective reproduction number, R, from 2004–05 to 2008–09 in the 28 Strategic Health Authorities in 
England for six possible scenarios for the under-estimation of vaccination coverage (the five SHAs in London are shown in red); 
the proportion of children recorded as unvaccinated who had received one dose and the proportion of children recorded as 
having received a single dose who had received two doses was assumed to be : a) 0%, b) 10%, c) 20%, d) 30%, e) 40% and f) 
50%.BMC Public Health 2008, 8:338 http://www.biomedcentral.com/1471-2458/8/338
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vaccination coverage. Most of those susceptible to measles
are unvaccinated children under 17 years old. Vaccinating
a significant proportion of these children in the highest
risk areas is necessary to remove the risk of an epidemic.
Primary care trusts should ensure that accurate systems are
in place to identify unimmunised children and to offer
catch-up immunisation for those not up to date for MMR.
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Table 3: The potential measles outbreak size (000s) by age group, under four scenarios of under-estimation of vaccine coverage.
Age group Assumed level of under-estimation in vaccine coverage*
20% 30% 40% 50%
0–4 years 22.7 13.0 5.9 1.3
5–10 years 49.9 26.8 11.3 2.2
11–17 years 39.3 22.3 9.5 1.8
18–24 years 3.3 2.0 0.9 0.2
25 years+ 9.9 5.8 2.7 0.6
Overall 125.2 70.1 30.6 6.3
In London 105.8 61.8 29.6 6.3
* The proportion of children recorded as unvaccinated who had received one dose and the proportion of children recorded as having received a 
single dose who had received two doses was assumed to be 20%, 30%, 40% or 50%.